Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter L Jager

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2002
Improving amino acid imaging: hungry or stuffed?Pieter L Jager
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2019
Small-voxel reconstructions significantly influence SUVs in PET imagingDaniëlle Koopman, Pieter L Jager, Jorn A van Dalen
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartmentAli Agool, Bart W Schot, Pieter L Jager, et al.
Nuclear Medicine Communications|April 22, 2004
Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PETPieter L Jager, Jourik A Gietema, Winette T A van der Graaf
Nuclear Medicine Communications|October 31, 2014
Influence of proton-pump inhibitors on stomach wall uptake of 99mTc-tetrofosmin in cadmium-zinc-telluride SPECT myocardial perfusion imagingMohamed Mouden, Karlijn S Rijkee, Nanno Schreuder, et al.
Cancer Research|December 18, 2003
Correspondence re: H. Barthel et al., 3'-deoxy-3'-[(18)F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res., 63: 3791-3798, 2003David C P Cobben, Philip H Elsinga, Aren van Waarde, et al.
Seminars in Nuclear Medicine|September 1, 2019
Adverse Events of Diagnostic Radiopharmaceuticals: A Systematic ReviewNanno Schreuder, Daniëlle Koopman, Pieter L Jager, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammationAren van Waarde, Pieter L Jager, Kiichi Ishiwata, et al.
EJNMMI Research|December 12, 2019
SUV variability in EARL-accredited conventional and digital PETDaniëlle Koopman, Pieter L Jager, Cornelis H Slump, et al.
Clinical Nuclear Medicine|February 28, 2003
Added value of attenuation-corrected myocardial perfusion scintigraphy in a patient with dextrocardiaRiemer H J A Slart, Jaep de Boer, Pieter L Jager, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2002
Improving amino acid imaging: hungry or stuffed?Pieter L Jager
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2019
Small-voxel reconstructions significantly influence SUVs in PET imagingDaniëlle Koopman, Pieter L Jager, Jorn A van Dalen
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartmentAli Agool, Bart W Schot, Pieter L Jager, et al.
Nuclear Medicine Communications|April 22, 2004
Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PETPieter L Jager, Jourik A Gietema, Winette T A van der Graaf
Nuclear Medicine Communications|October 31, 2014
Influence of proton-pump inhibitors on stomach wall uptake of 99mTc-tetrofosmin in cadmium-zinc-telluride SPECT myocardial perfusion imagingMohamed Mouden, Karlijn S Rijkee, Nanno Schreuder, et al.
Cancer Research|December 18, 2003
Correspondence re: H. Barthel et al., 3'-deoxy-3'-[(18)F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res., 63: 3791-3798, 2003David C P Cobben, Philip H Elsinga, Aren van Waarde, et al.
Seminars in Nuclear Medicine|September 1, 2019
Adverse Events of Diagnostic Radiopharmaceuticals: A Systematic ReviewNanno Schreuder, Daniëlle Koopman, Pieter L Jager, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammationAren van Waarde, Pieter L Jager, Kiichi Ishiwata, et al.
EJNMMI Research|December 12, 2019
SUV variability in EARL-accredited conventional and digital PETDaniëlle Koopman, Pieter L Jager, Cornelis H Slump, et al.
Clinical Nuclear Medicine|February 28, 2003
Added value of attenuation-corrected myocardial perfusion scintigraphy in a patient with dextrocardiaRiemer H J A Slart, Jaep de Boer, Pieter L Jager, et al.
Pageof 11